NCT00472693 · Interventional trial
Bevacizumab and Abraxane as Second-line Therapy in Triple Negative Metastatic Breast Cancer
Overall registry status Completed
Phase 2
Conditions Breast Cancer
Delaware Valley sites
- Abramson Cancer Center at University of Pennsylvania · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory